Added to YB: 2025-03-27
Pitch date: 2025-03-26
BEAT [bullish]
HeartBeam, Inc.
Author Info
Company Info
HeartBeam, Inc., a medical technology company, primarily focuses on developing and commercializing ambulatory electrocardiogram solutions that enable the detection and monitoring of cardiac disease inside and outside a healthcare facility setting.
Market Cap
$66.8M
Pitch Price
N/A
Price Target
N/A
Dividend
N/A
Sector
Health Care Equipment and Supplies
Category
growth
Heartbeam: The Device
BEAT: Novel credit card-sized 12-lead ECG device with FDA hardware clearance, awaiting software approval. Studies show comparable accuracy to standard ECGs. $52M market cap, no debt, $11.5M raised. Commercialization in H2 2025 targeting concierge/direct pay markets. MDB Capital backing. Risks: FDA software approval, commercialization challenges.
Read full article (17 min)